← Compounds
Empagliflozin (Jardiance)
off-label Rx · medium oversightFDA-approvedSGLT2 inhibition; cardio-renal protection
Overview
SGLT2 inhibitor; renal glucose excretion with cardiometabolic and emerging longevity interest.
How it works
- SGLT2 inhibition → glucosuria
- Cardio-renal protection
Dosing
10–25 mg once daily.
Oral10 mg standardrange —–25 mg· daily
Cycling
- Continuous
Side effects
- Common
- Genital mycotic infections
- Volume depletion
- Warnings
- Rare euglycemic DKA
Verified citations
2 · PubMed-checked- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.clinicalPMID 27299675 ↗
- Empagliflozin in the treatment of heart failure.reviewPMID 38865086 ↗
Reconstitution
Not applicable — this compound is oral. No vial reconstitution needed.
Legal / compounding
FDA-approved
- FDA
- Approved
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.